Zeng and colleagues recently described that BRAFV600E mutated LCH-patients have significantly higher numbers of lesional Foxp3+ regulatory T cells and increased PD-L1 expression by LCH-cells when compared to BRAFWT patients (80). Here, FOXP3 is linked to Langerhans cell histiocytosis.